article thumbnail

STAT+: With a potent new medicine, Merck marks a return to cardiology

STAT News

NEW ORLEANS — A new medicine represents a dramatic advance for patients with a rare condition called pulmonary arterial hypertension — and a return to heart disease for Merck, which long had a legendary presence in cardiology. Continue to STAT+ to read the full story…

article thumbnail

UK regulator backs Amarin’s cardiology drug Vazkepa

pharmaphorum

Amarin’s Vazkepa cardiology drug has been backed by the UK’s drugs regulator, following approval in Europe at the end of March. . The Medicines and Healthcare products Regulatory Agency (MHRA) granted a marketing authorisation for Vazkepa (icosapent ethyl) as a treatment to reduce risk of cardiovascular events in high-risk patients.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

#news #biotech New atlas of the human heart could guide personalized medicine in cardiology

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: New atlas of the human heart could guide personalized medicine in cardiology.New atlas of the human heart could guide personalized medicine in cardiology arlene.weintraub Fri, 09/25/2020 – … Continue reading → (..)

article thumbnail

PI Savors Opportunity to Advance Medicine

Velocity Clinical Research

“Without clinical research, there would be little if any development of new medicines,” says Isabelle Schenkenberger, MD. An Internal Medicine Specialist since 2000, Dr. Schenkenberger has practiced at her own clinic since 2002. The post PI Savors Opportunity to Advance Medicine appeared first on Velocity Clinical Research.

article thumbnail

LUCA Science Announces Joint Research With Division of Cardiology, Field of Internal Medicine, Nagoya University Graduate School of Medicine on the Development of Mitochondrial Therapy for Myocardial Infarction (Cardiac Ischemic-reperfusion Injury)

BioTech 365

LUCA Science Announces Joint Research With Division of Cardiology, Field of Internal Medicine, Nagoya University Graduate School of Medicine on the Development of Mitochondrial Therapy for Myocardial Infarction (Cardiac Ischemic-reperfusion Injury) LUCA Science Announces Joint Research With Division of Cardiology, … Continue reading →

article thumbnail

Telemedicine needs to be integrated into cardiology training, experts recommend

Scienmag

While patients are embracing telemedicine, significant numbers of cardiology trainees are uncomfortable with telemedicine according to survey results reported in the Canadian Journal of Cardiology Philadelphia, May 12, 2021 – The COVID-19 pandemic has resulted in an abrupt change in healthcare delivery, including a shift from in-person visits (..)

article thumbnail

American College of Cardiology to collaborate with Amgen, Veradigm to optimize ACS Care

Scienmag

National study will accelerate initiation of lipid lowering therapies in ACS patients to prevent future cardiovascular events The American College of Cardiology, in collaboration with Amgen and Veradigm, today announced a new national study to transform care for acute coronary syndrome (ACS) patients at risk for future cardiovascular events.